Intersystems Biology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersystems biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersystems Biology Today - Breaking & Trending Today

Senda Biosciences and Nestlé Health Science announce exclusive global development & option agreement for Senda's Intersystems Biology-based metabolic health products


Share this article
Share this article
CAMBRIDGE, Mass., Jan. 26, 2021 /PRNewswire/  Senda Biosciences, a therapeutics platform company creating novel categories of medicines based on a new field of science called Intersystems Biology, announced today that it has entered into a strategic collaboration with Nestlé Health Science for the development of novel nutritional therapies for a wide range of metabolic conditions, including obesity and glycemia. 
The companies will focus initially on accelerating first-in-human clinical studies on up to three small molecule compounds developed by Senda, leveraging the capabilities of Nestlé Health Science, a global leader in the science of nutrition. The compounds have been rationally designed based on Senda s Intersystems Biology discovery platform, and screened through Senda s proprietary bioassays for their potential to improve metabolic health. In preclinical studies these compounds have shown the ability to achieve susta ....

United Kingdom , Hans Juergen Woerle , Guillaume Pfefer , Senda Biosciences , Health Science , Health Science Nhsc , Intersystems Biology , Health Science Chief Medical , Scientific Officer Hans Juergen , ஒன்றுபட்டது கிஂக்டம் , அனுப்புதல் உயிர் அறிவியல் , ஆரோக்கியம் அறிவியல் , ஆரோக்கியம் அறிவியல் தலைமை மருத்துவ , அறிவியல் அதிகாரி ஹான்ஸ் ஜூர்கன் ,

Senda Biosciences Announces Formation of World-Class Scientific Advisory Board


Share this article
Share this article
CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda s SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda s leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells coevolved over millennia define health and disease.
We are thrilled to have attracted some of the brightest minds in their fields to our SAB, says Guillaume Pfefer, PhD, chief executive officer of Senda. The deep expertise of the SAB will be pivotal to the advancement of our novel approach to medicines development, rooted in an unparalleled understanding of interspecies molecular c ....

United States , Dana Farber Cancer Institute , California Institute Of Technology , United Kingdom , University Of California San Diego , Steve Jacobsen , Roger Innes , Wendy Garrett , Ramnik Xavier , Los Angeles , Prnewswire Senda Biosciences , Guillaume Pfefer , Randy Schekman , James Rothman , Senda Biosciences , Wendys Garrett , Luke Oneill , Vijay Kuchroo , Royal Society , University Of Colorado Boulder , Trinity College Dublin , Inflammation Research Group , International Cytokine , University Of Cambridge , Immunologic Diseases At Harvard Medical School , American Association For The Advancement Of Science ,